Combined hepatocellular cholangiocarcinoma(CHC) accounts for 0.4%-14.2% of primary liver cancer cases and possesses pathological features of both hepatocellular
With partial support by the National Natural Science Foundation of China,Prof.Xu Rong(徐戎)at the Department of Pharmacology,School of Basic Medicine,Tongji Med